• Acute Care
    Medicure achieved a ranking as
    A 2016 TSX Venture 50 Company
  • Acute Care
    Medicure Focuses On
    Acute Care
    Hospital Products
  • Aggrastat HDB FDA Approved
    Aggrastat HDB
    The high-dose bolus (HDB) dosing regimen has been added to the Aggrastat (tirofiban HCI) Prescribing Information.
  • Medicure Investments
    medicure is traded
    on TSX Venture (MPH)
    The Company’s primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban HCI).